Delivery Order HHSN268201600011I-HHSN26800001
- The National Heart Lung and Blood Institute (NHLBI) awarded a $7,334,044.67 cost-reimbursement contract to Beckman Research Institute of the City of Hope, a nonprofit organization, to provide support for the Production Assistance for Cellular Therapies (PACT) Program's cell processing facilities. This contract, which has no set-aside designation, will assist with the production and development of cellular therapies through May 2018. The PACT Program aims to advance cellular therapy research...
- This is a federal contract award to Beckman Research Institute of the City of Hope, a nonprofit organization, to provide cell manufacturing and process development services for regenerative cell therapies. The contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), under the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery, indefinite quantity (IDIQ) contract...
- This delivery order for $662,778.28 was awarded against the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) master IDIQ by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Beckman Research Institute Of The City Of Hope, a nonprofit organization located in Irwindale, California. The order is for cell manufacturing and process development services for research stem cell-derived cardiomyocyte...
- This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Beckman Research Institute Of The City Of Hope, a nonprofit organization, for PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - CELL PROCESSING FACILITIES services. The $1,493,579.31 delivery order is part of the larger PACT-CPF indefinite delivery/indefinite quantity (IDIQ) contract. The delivery order does not have a set-aside designation....
- This federal contract award is for PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL-TASK AREA 2, PCT0050-01: HESC-DERIVED CARDIOMYOCYTE PROGENITOR CELLS FOR PRECLINICAL ANIMAL STUDIES. The contract, with a potential value of $211,854.50, was awarded on October 20, 2020 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Beckman Research Institute of the City of Hope, a non-profit...
- This is a $1,677,572.00 delivery order awarded by the National Institutes of Health (NIH) National Heart Lung and Blood Institute to the Beckman Research Institute of the City of Hope, a nonprofit organization, for cell manufacturing and process development services. The work is being performed under the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery, indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation....
- The Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute awarded a $156,290 delivery order against the Production Assistance for Cellular Therapies - Cell Processing Facilities indefinite-delivery/indefinite-quantity contract vehicle. The Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, will provide cell manufacturing and process development services as part of the LOVO PACT...
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $1,180,889.00 firm-fixed-price delivery order contract to the University of Miami Office of Research Administration - School of Medicine Division for "Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities". This delivery order is part of a larger PACT-CPF Indefinite Delivery Contract vehicle held by the University of Miami....
- This is a $6,000,000.00 federal contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to the Beckman Research Institute of the City of Hope, a nonprofit organization. The contract is for biomedical management and support services related to the Islet Cell Distribution Coordinating Center program. The contract is a definitive contract with a cost-no-fee pricing type and does not have a...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
- HHSN268201600011IIndefinite Delivery Contract
- HHSN268201600011I-HHSN26800001Delivery Order
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $872,250 to the Beckman Research Institute of the City of Hope, a nonprofit medical research organization based in Duarte, California. This contract was issued under the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities master IDIQ and covers Administrative and Regulatory Program Support Services under Task Area #1. The award was made on August 1, 2016, with a completion date of June 30, 2021, and is structured as a firm-fixed-price contract with no set-aside designation. The work is being performed in Minneapolis, Minnesota. The Beckman Research Institute was selected to support cellular therapy production infrastructure development, leveraging its established expertise in advanced biomedical research and translational science. As a registered federal contractor since 2001, the institute brings significant capabilities in research and development services across multiple disciplines, including immunotherapy and personalized medicine. This engagement aligns with the NHLBI's mission to support the development of cellular therapy technologies and manufacturing capacity, while the institute's experience delivering specialized research services and regulatory support positions it well to advance the agency's cellular therapies program objectives.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities (CPFs) | NHLBI-ECB-HB-2016-09-JB | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/27/15, 7:25 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $183.3k | 6/30/20 | |
| P00003 | Exercise an Option | $180.1k | 7/1/19 | |
| 2 | Exercise an Option | $179.5k | 6/15/18 | |
| 1 | Exercise an Option | $173.3k | 6/30/17 | |
| Not listed | Not listed | $156.1k | 8/1/16 |